Episode 11 of the FIP Development Goals Digital Programme is focused on “advancing integrated services”. The goal visualizes a people-centred and integrated health care provision that is based on an interprofessional and cross-setting seamless continuum including pharmacist-delivered professional services. Through the lenses of pharmaceutical sciences, workforce, education, and practice, this event aims to advance the ideals of integrated service delivery in a way that benefits our patients and lead to improvement of health outcomes.

Event outcomes:
1. Describe and explain the components of FIP DG 7 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 7 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 7
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

New niche & digital actors as well as on-line pharmacies are entering the pharmacy market. Healthcare is becoming more and more digital, and the development is partly exponential, and partly driven by the consumers – as such there is a consumerism of healthcare. How will this affect the patients, the current pharmacy model & the healthcare systems?

Learning objectives:

• Understand the changing landscape of healthcare and pharmacy
• Identify how new actors use technology to transform pharmacy services
• Understand how digital transformation and tools support new business models and services, as well as is shaping a new patient/consumer behaviour
• Describe how FIPs PHC strategy and the DGs can be used to transform pharmacy practice
• Define a strategy for transform pharmacy linked to the “new normal”

Many jurisdictions around the world have implemented Apology Legislation and non-punitive medication error reporting requirements in order to create transparency, learning and prevention to enhance patient confidence and patient safety in the healthcare system and work towards creating a Just Culture or a Culture of Safety in health professionals and practice sites.   This webinar will present the value and the experiences of jurisdictions, which have enacted legislation and additional standards of care, for community pharmacy practice. Spread and scale of learning through international collaboration exemplified by the international medical regulatory authority will also be presented.

Learning Objectives:

1)      The importance sections of the FIP #4757 (Pharmacists Role in Medication without Harm) and Culture of Safety.

2)      The value of Apology Legislation on medication error resolution, transparency and patient confidence.

3)      The value of centralised medication error reporting in community pharmacy practice to enhance patient safety, quality assurance and prevent errors.

4)      The importance of international collaboration for the evolution to “Just Culture” and supportive legislation.

Participantes

– Ema Paulino , Membro do Comité Executivo/ Secretária Profissional da FIP

– Eduardo Tavares, Presidente da Entidade Reguladora Independente da Saúde (ERIS)

– Artur Nhanengue, Diretor dos Serviços Farmacêuticos do Hospital Central de Maputo (HCM) Moderador Santos Nicolau, Bastonário da Ordem dos Farmacêuticos de Angola

The FIP Pharmacy Practice Research SIG (PPR SIG) was created with the main scope of increasing pharmacy practice contributions to global health through the provision of greater access to the latest high-quality international pharmacy practice research. The PPR SIG also aims to cultivate an international forum for the dissemination of quality, international pharmacy practice research for all stakeholders and stimulate communication, discussion, networking, and collaboration between international pharmacy practice stakeholders.

Based on this objective, this PPR virtual summer meeting aims to increase the quality and quantity of pharmacy practice research by exchanging and disseminating information at an international level. New networks and collaborations will be established on major themes for experienced researchers and higher degree students.

The seminar will provide the overview, results and case studies regarding the rapid response of pharmacy education institutions for COVID 19. It will also highlight changes developed during the response to COVID-19 that serve as a template for improved education and practices for the future. 

Learning objectives:  

1. Discuss the survey results regarding the impact of COVID-19 on pharmacy education & workforce development. 
2. Determine best practice changes in response to COVID-19 through presentation of individual case studies. 
3. Identify practice and process transformations that resulted in improvements for the future.

Moderator: Kerstin Wagner

Panellists:

• Daniel Sanabria
• Mark Stuart
• Helen Zhang.